These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate. Loughran PA; Roman LJ; Miller RT; Masters BS Arch Biochem Biophys; 2001 Jan; 385(2):311-21. PubMed ID: 11368012 [TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of lauric acid omega-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein. Chaurasia CS; Alterman MA; Lu P; Hanzlik RP Arch Biochem Biophys; 1995 Feb; 317(1):161-9. PubMed ID: 7872779 [TBL] [Abstract][Full Text] [Related]
4. Human fatty acid omega-hydroxylase, CYP4A11: determination of complete genomic sequence and characterization of purified recombinant protein. Kawashima H; Naganuma T; Kusunose E; Kono T; Yasumoto R; Sugimura K; Kishimoto T Arch Biochem Biophys; 2000 Jun; 378(2):333-9. PubMed ID: 10860550 [TBL] [Abstract][Full Text] [Related]
5. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium. Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the n-alkane and fatty acid hydroxylating cytochrome P450 forms 52A3 and 52A4. Scheller U; Zimmer T; Kärgel E; Schunck WH Arch Biochem Biophys; 1996 Apr; 328(2):245-54. PubMed ID: 8645001 [TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of benzoate-para-hydroxylase, a cytochrome P450 (CYP53A1), from Aspergillus niger. Faber BW; van Gorcom RF; Duine JA Arch Biochem Biophys; 2001 Oct; 394(2):245-54. PubMed ID: 11594739 [TBL] [Abstract][Full Text] [Related]
8. Expression of rabbit cytochromes P4504A which catalyze the omega-hydroxylation of arachidonic acid, fatty acids, and prostaglandins. Roman LJ; Palmer CN; Clark JE; Muerhoff AS; Griffin KJ; Johnson EF; Masters BS Arch Biochem Biophys; 1993 Nov; 307(1):57-65. PubMed ID: 8239664 [TBL] [Abstract][Full Text] [Related]
10. Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases. Hoch U; Zhang Z; Kroetz DL; Ortiz de Montellano PR Arch Biochem Biophys; 2000 Jan; 373(1):63-71. PubMed ID: 10620324 [TBL] [Abstract][Full Text] [Related]
11. Protein expression, characterization, and regulation of CYP4F4 and CYP4F5 cloned from rat brain. Kawashima H; Kusunose E; Thompson CM; Strobel HW Arch Biochem Biophys; 1997 Nov; 347(1):148-54. PubMed ID: 9344476 [TBL] [Abstract][Full Text] [Related]
12. An enzymatically active chimeric protein containing the hydrophilic form of NADPH-cytochrome P450 reductase fused to the membrane-binding domain of cytochrome b5. Gilep AA; Guryev OL; Usanov SA; Estabrook RW Biochem Biophys Res Commun; 2001 Jun; 284(4):937-41. PubMed ID: 11409883 [TBL] [Abstract][Full Text] [Related]
13. Glu-320 and Asp-323 are determinants of the CYP4A1 hydroxylation regiospecificity and resistance to inactivation by 1-aminobenzotriazole. Dierks EA; Davis SC; Ortiz de Montellano PR Biochemistry; 1998 Feb; 37(7):1839-47. PubMed ID: 9485309 [TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of recombinant cytochrome P450TYR expressed at high levels in Escherichia coli. Halkier BA; Nielsen HL; Koch B; Møller BL Arch Biochem Biophys; 1995 Oct; 322(2):369-77. PubMed ID: 7574710 [TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 4A4: expression in Escherichia coli, purification, and characterization of catalytic properties. Nishimoto M; Clark JE; Masters BS Biochemistry; 1993 Aug; 32(34):8863-70. PubMed ID: 8364033 [TBL] [Abstract][Full Text] [Related]
16. Human prostate CYP3A5: identification of a unique 5'-untranslated sequence and characterization of purified recombinant protein. Yamakoshi Y; Kishimoto T; Sugimura K; Kawashima H Biochem Biophys Res Commun; 1999 Jul; 260(3):676-81. PubMed ID: 10403825 [TBL] [Abstract][Full Text] [Related]
17. Active site structure and substrate specificity of cytochrome P450 4A1: steric control of ligand approach perpendicular to heme plane. Bambal RB; Hanzlik RP Biochem Biophys Res Commun; 1996 Feb; 219(2):445-9. PubMed ID: 8605007 [TBL] [Abstract][Full Text] [Related]
18. A continuous spectrophotometric assay for P450 BM-3, a fatty acid hydroxylating enzyme, and its mutant F87A. Schwaneberg U; Schmidt-Dannert C; Schmitt J; Schmid RD Anal Biochem; 1999 May; 269(2):359-66. PubMed ID: 10222011 [TBL] [Abstract][Full Text] [Related]
19. Expression of functionally active cytochrome b5 in Escherichia coli: isolation, purification, and use of the immobilized recombinant heme protein for affinity chromatography of electron-transfer proteins. Chudaev MV; Usanov SA Biochemistry (Mosc); 1997 Apr; 62(4):401-11. PubMed ID: 9275279 [TBL] [Abstract][Full Text] [Related]
20. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3. Peters MW; Meinhold P; Glieder A; Arnold FH J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]